Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In
  • Log Out

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
  • Log Out
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
LetterLetter

Disease Activity Monitoring in Rheumatoid Arthritis in Daily Practice: Experiences with METEOR, a Free Online Tool

ROSANNE KOEVOETS, CORNELIA F. ALLAART, DÉSIREÉ M.F.M. van der HEIJDE and TOM W.J. HUIZINGA
The Journal of Rheumatology December 2010, 37 (12) 2632-2633; DOI: https://doi.org/10.3899/jrheum.100552
ROSANNE KOEVOETS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: r.koevoets@lumc.nl
CORNELIA F. ALLAART
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DÉSIREÉ M.F.M. van der HEIJDE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOM W.J. HUIZINGA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters
PreviousNext
Loading

To the Editor:

In a recent study, quality indicators for monitoring patients with rheumatoid arthritis (RA) were developed that prescribe frequent monitoring and registration of disease activity and functionality, together with subsequent treatment adjustments1. From the literature it is clear that frequent monitoring of disease activity with adjusted treatment improves outcome2. However, there is also evidence that in daily practice, treatment steered according to disease activity scores is not yet routine3.

To provide a tool to easily incorporate monitoring and registration of disease activity and functionality into daily routine, a group of international rheumatologists has developed the METEOR program. Our aim is to inform all rheumatologists about the first experiences with METEOR in daily practice and the tool itself.

METEOR stands for Measurement of Efficacy of Treatment in the Era of Outcome in Rheumatology. The software tool, designed by and for rheumatologists, is available online for free for any interested hospital (Figure 1). Only a minimum of actions is required to calculate and register both disease activity and functional ability. Disease activity can be automatically calculated according to one’s preference as a Disease Activity Score (DAS), 28-joint count DAS (DAS28), Simplified Disease Activity Index (SDAI), Clinical Disease Activity Index (CDAI), or joint count. Medication can be registered at the same time and the program then provides a table or graph of the disease course and treatment over time. There is a possibility to fill in free text, and assessment of patient-reported outcomes is included within the program. At all times, specialized data reports can be generated to get insight into your own patients.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Disease Activity Score manikin of the METEOR program represents a fictional case.

At this moment 90 hospitals in 32 different countries are joining the project either by registering data using the METEOR tool, or by linking existing databases with the international METEOR database (Table 1). Data have been entered for almost 8000 patients. The mean baseline DAS is 2.0 (SD 1.0, n = 4799) and the mean DAS28 3.3 (SD 1.4), representing a mean low disease activity. Mean Health Assessment Questionnaire score is 0.8 (SD 0.8, n = 2944).

View this table:
  • View inline
  • View popup
Table 1.

Patient numbers in participating countries per July 2010 (hospitals not yet including patients are not shown).

To guide the implementation of frequent monitoring as well as the METEOR tool, a qualitative study was performed to identify inhibiting and enhancing factors. Interview topics included practicalities of disease activity measurements, the content of the consultation, advantages and disadvantages of the METEOR tool, and accomplishments of the goals of METEOR. Semistructured interviews were used to get feedback from 17 rheumatologists in 6 Dutch hospitals, in both academic and peripheral settings.

All rheumatologists indicated that they are aware of the importance and benefits of DAS-driven therapy. Fifty percent spontaneously mentioned that having METEOR in the office increased their awareness of the need for monitoring and makes them perform physical examinations more frequently and thoroughly, which is the main goal of METEOR. Data-base-building and benchmarking, 2 other goals of METEOR, are less known and used. Rheumatologists find the METEOR tool user-friendly, not time-consuming, and practical. The majority mentioned that the visual presentation with graphics or tables was very helpful to discuss results and the need for therapy adjustments with patients. Most also indicated that there is some overlap between the existing medical record and data sources and the METEOR tool, which may require local technical solutions.

We conclude that in the care of patients with RA, METEOR can be a valuable and easy to use tool to help rheumatologists register disease activity on a regular basis and adjust the medication to achieve low disease activity.

Interested readers can find more information at the Website (www.meteorfoundation.com) or contact the local country representative (http://meteorfoundation.com/Portals/0/Current%20Country%20Leads.pdf).

Footnotes

  • The METEOR application was funded by an unrestricted grant from Pfizer and Roche.

REFERENCES

  1. 1.↵
    1. van Hulst LT,
    2. Fransen J,
    3. den Broeder AA,
    4. Grol R,
    5. van Riel PL,
    6. Hulscher ME
    . Development of quality indicators for monitoring of the disease course in rheumatoid arthritis. Ann Rheum Dis 2009;68:1805–10. Erratum in: Ann Rheum Dis 2010;69:336.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Grigor C,
    2. Capell H,
    3. Stirling A,
    4. McMahon AD,
    5. Lock P,
    6. Vallance R,
    7. et al.
    Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 2004;364:263–9.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Pincus T,
    2. Segurado OG
    . Most visits of most patients with rheumatoid arthritis to most rheumatologists do not include a formal quantitative joint count. Ann Rheum Dis 2006;65:820–2.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 37, Issue 12
1 Dec 2010
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Disease Activity Monitoring in Rheumatoid Arthritis in Daily Practice: Experiences with METEOR, a Free Online Tool
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Disease Activity Monitoring in Rheumatoid Arthritis in Daily Practice: Experiences with METEOR, a Free Online Tool
ROSANNE KOEVOETS, CORNELIA F. ALLAART, DÉSIREÉ M.F.M. van der HEIJDE, TOM W.J. HUIZINGA
The Journal of Rheumatology Dec 2010, 37 (12) 2632-2633; DOI: 10.3899/jrheum.100552

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Disease Activity Monitoring in Rheumatoid Arthritis in Daily Practice: Experiences with METEOR, a Free Online Tool
ROSANNE KOEVOETS, CORNELIA F. ALLAART, DÉSIREÉ M.F.M. van der HEIJDE, TOM W.J. HUIZINGA
The Journal of Rheumatology Dec 2010, 37 (12) 2632-2633; DOI: 10.3899/jrheum.100552
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Footnotes
    • REFERENCES
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters

Related Articles

Cited By...

More in this TOC Section

  • Some Key Issues Relating to the Reporting and Interpretation of Time-to-event Data
  • Dr. Griffiths et al reply
  • Baricitinib for Refractory Eosinophilic Fasciitis: Myth or Reality?
Show more Letters

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire